PWAM
REGN icon

Papamarkou Wellner Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Papamarkou Wellner Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$295K Hold
382
– – 0.18% 61
2025
Q4 		$295K Buy
382
+17
+5% +$11.5K 0.18% 67
2025
Q3 		$205K Buy
+365
New +$206K 0.13% 72
2025
Q2 		– Sell
-340
Closed -$216K – 87
2025
Q1 		$216K Buy
+340
New +$234K 0.15% 73

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Papamarkou Wellner Asset Management's REGN Position: Q1 2026 in Review

Papamarkou Wellner Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 382 shares worth $295K. The position accounts for 0.18% of the portfolio, ranked #61.

Papamarkou Wellner Asset Management first reported a position in REGN in Q1 2025 and has held it in 4 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Papamarkou Wellner Asset Management held 382 shares of Regeneron Pharmaceuticals worth $295K as of Q1 2026.
  • Papamarkou Wellner Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.18% of Papamarkou Wellner Asset Management's portfolio in Q1 2026, its #61 holding.
  • Papamarkou Wellner Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Papamarkou Wellner Asset Management's 13F filing for Q1 2026, filed 15 May 2026.